Showing 1 - 5 results of 5 for search 'Chiara Callegari', query time: 0.02s Refine Results
  1. 1
    P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-COV-2 VACCINATION.

    P1513: REDUCTION OF THE PROPHYLACTIC EFFECT OF TIXAGEVIMAB-CILGAVIMAB IN THE OMICRON ERA IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND WITHOUT ANTIBODY RESPONSE FOLLOWING SARS-CO... by Chiara Callegari, Martina Mutti, Alessandra Soravia, Pietro Lauzzana, Davide Lazzarotto, Maddalena Peghin, Stefano Cordella, Renato Fanin, Anna Candoni

    Published 2023-08-01
    Get full text
    Article
  2. 2
    PB2214: CORRELATION BETWEEN HEMORRHAGIC EVENTS AND IPSET SCORE IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

    PB2214: CORRELATION BETWEEN HEMORRHAGIC EVENTS AND IPSET SCORE IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA by Luca Tosoni, Umberto Pizzano, Rikard Mullai, Gianluca Morelli, Giulia Battaglia, Chiara Callegari, Maria Elena Zannier, Davide Lazzarotto, Erica Simeone, Carla Filì, Daniel Alzetta, Daniela Damiani, Renato Fanin, Mario Tiribelli

    Published 2023-08-01
    Get full text
    Article
  3. 3
    PB1860: HIGH EFFICACY OF HYPOMETHYLATING AGENTS PLUS VENETOCLAX COMBINATION THERAPY IN ELDERLY PATIENTS AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY: A REAL-LIFE EXPERIENCE.

    PB1860: HIGH EFFICACY OF HYPOMETHYLATING AGENTS PLUS VENETOCLAX COMBINATION THERAPY IN ELDERLY PATIENTS AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY: A REAL-LIFE EXPERIENCE. by Maria Elena Zannier, Daniel Alzetta, Carla Fili, Erica Simeone, Davide Lazzarotto, Chiara Callegari, Giulia Battaglia, Gianluca Morelli, Luca Tosoni, Umberto Pizzano, Rikard Mullai, Daniela Damiani, Renato Fanin, Mario Tiribelli

    Published 2023-08-01
    Get full text
    Article
  4. 4
    The triple A (AAA) model globally recapitulates adverse outcomes in essential thrombocythemia

    The triple A (AAA) model globally recapitulates adverse outcomes in essential thrombocythemia by Luca Tosoni, Gian Luca Morelli, Gaia Tomadini, Davide Lazzarotto, Carla Filì, Erica Simeone, Maria Elena Zannier, Chiara Callegari, Matteo Fanin, Giulia Battaglia, Melissa Bergnach, Daniela Damiani, Renato Fanin, Mario Tiribelli

    Published 2024-10-01
    Get full text
    Article
  5. 5
    P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”.

    P549: EFFICACY AND TOXICITY OF CPX-351 IN PATIENTS WITH HIGH-RISK ACUTE MYELOID LEUKEMIA (AML): THE MULTICENTER REAL-WORLD EXPERIENCE FROM THE “ITALIAN TRIVENETO REGISTRY”. by Gian Luca Morelli, Carla Fili, Endri Mauro, Anna Maria Scattolin, Federico Mosna, Carmela Gurrieri, Gianpaolo Nadali, Albana Lico, Alessandra Sperotto, Eleonora DE Bellis, Mariagrazia Michieli, Teresa Aloisi, Davide Lazzarotto, Maria Elena Zannier, Erica Simeone, Daniel Alzetta, Giulia Battaglia, Chiara Callegari, Umberto Pizzano, Rikard Mullai, Luca Tosoni, Mario Tiribelli, Renato Fanin

    Published 2023-08-01
    Get full text
    Article

Search Tools: